Mounjaro in the Dubai heat: storage, hydration and side effects in summer
PAGE
By PAGE Editor
Mounjaro (tirzepatide) is a once-weekly injection used in medical weight management. It acts on two hormone receptors, GIP and GLP-1, which are involved in regulating appetite and blood sugar.
For patients receiving doctor-supervised Mounjaro weight loss injections in Dubai, the summer months bring practical considerations to treatment. High temperatures affect how pens should be stored, how much fluid the body needs and how side effects are managed.
How Mounjaro pens should be stored
Unopened Mounjaro pens are kept in the fridge at 2°C to 8°C, in their original carton. They should never be frozen.
The time a pen can spend outside the fridge depends on the type of pen. The US prescribing information for the single-dose pen allows up to 21 days unrefrigerated at no more than 30°C. Lilly's UK medical information for the multi-dose KwikPen allows up to 30 days after first use, at temperatures up to 30°C.
Both presentations share the same upper limit of 30°C. Because the number of days differs, the leaflet supplied with your pen is the reference to follow. Summer temperatures in Dubai are often well above 30°C, which makes careful handling important.
Keeping Mounjaro pens cool in daily life and on trips
Cars parked in the sun can heat up far beyond the outside temperature. Leaving a pen in a car, even for a short time, is best avoided. Pens are also best kept away from direct sunlight and from heat sources such as a sunny windowsill.
For longer trips, an insulated bag with a cool pack can help keep pens within the recommended temperature range. The pen should not touch the cool pack directly, as contact with a frozen pack could freeze the medication.
At home, a main shelf of the fridge is generally a safer place for pens than the door or the area near the back wall. Temperatures in those spots can vary more. Items stored near the back can sometimes freeze.
When flying, pens are best carried in hand luggage. Aircraft holds can become very cold. Checked bags can also be delayed. If a pen has been exposed to high heat or has frozen, a pharmacist or doctor can advise whether it is still safe to use.
Side effects and the risk of dehydration
Digestive side effects are reported more often with tirzepatide than with placebo, particularly after a dose increase. In the weight management trials summarised in the US prescribing information for tirzepatide, nausea affected around 25% to 29% of participants on the 5 mg to 15 mg doses. The figure on placebo was 8%.
Vomiting and diarrhoea lead to fluid loss, which can contribute to dehydration more quickly in hot weather. Drinking water regularly through the day, rather than waiting until you feel thirsty, is a sensible habit during the summer. Signs of dehydration include dizziness, a dry mouth, dark urine and passing less urine than usual.
If vomiting prevents you from keeping fluids down, seek medical advice immediately. The UK Medicines and Healthcare products Regulatory Agency (MHRA) also gives specific advice for people on GLP-1 medications. Severe abdominal pain that extends to the back and does not ease needs urgent help.
In hot weather, it can be difficult to tell whether nausea, headache or dizziness comes from the heat or from the medication. If symptoms are severe, or do not improve after resting somewhere cool and drinking water, seek medical advice. Fainting or confusion needs emergency help: call an ambulance on 998.
Eating patterns that may help in the first weeks
Smaller, lighter meals may be easier to tolerate than large, rich ones, particularly in the first weeks at a new dose. Eating slowly and stopping when you feel full can also help reduce nausea.
Your doctor will increase the dose in steps, guided by your progress and your tolerance of the medication. Most patients start on 2.5 mg, and the available doses rise through 5 mg, 7.5 mg, 10 mg and 12.5 mg to 15 mg. A dose increase does not happen automatically after four weeks.
If nausea or constipation continues, your doctor can slow the dose increases or prescribe medication to help with the symptoms.
Exercising safely in the summer
Physical activity remains an important part of treatment, alongside nutrition and medication. Exercising in the early morning, in the evening or indoors can reduce heat exposure. Carrying water to each session and stopping if you feel dizzy or unwell are simple precautions.
The US Physical Activity Guidelines recommend muscle-strengthening activities on at least two days a week. Resistance training of this kind can help preserve muscle while you lose weight.
Adequate protein also supports muscle during weight loss. A common general reference range is roughly 1.2 to 1.6 g of protein per kilogram of body weight per day. A doctor or dietitian can personalise this target.
Planning Mounjaro injections around summer travel
Travel and changes in routine can make it harder to inject on the usual day. The Mounjaro prescribing information allows a missed dose to be taken within four days, provided at least three days separate it from the next dose. The weekly injection day can also be changed, as long as at least three days separate the two doses.
Rules on carrying injectable medication differ between countries. Checking the destination's requirements and keeping a copy of the prescription with your medication is advisable. A review with your doctor before a long trip allows the plan to be adjusted in advance.
Consistent weekly dosing is important, as weight loss with Mounjaro develops over months. SURMOUNT-1, a large Phase 3 clinical trial, followed adults with obesity or overweight for 72 weeks. Participants taking the top dose achieved an average weight loss of around 20% of body weight.
Mounjaro is a prescription medication. Starting it is not a decision to take alone. A doctor's review helps establish whether the treatment is safe and appropriate in each case.
HOW DO YOU FEEL ABOUT FASHION?
COMMENT OR TAKE OUR PAGE READER SURVEY
Featured
Mounjaro (tirzepatide) is a once-weekly injection used in medical weight management. It acts on two hormone receptors, GIP and GLP-1, which are involved in regulating appetite and blood sugar.